1796938
Last Update Posted: 2014-10-20
Recruiting has ended
All Genders accepted | 18 Years-70 Years |
40 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects
To investigate the Pharmacokinetics (PK) of oral administered Lacosamide in renal impaired subjects and healthy subjects.
Eligibility
Relevant conditions:
Healthy
Renal Impairment
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov